Loxo Oncology is a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers
Loxo Oncology is a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers. Their pipeline focuses on cancers that are uniquely dependent on single gene abnormalities, enabling targeted therapies.